Psychedelics and ketamine/esketamine in depressive disorders: biological mechanisms and associated neuroimaging and clinical changes

Psychedelics and ketamine/esketamine in depressive disorders: biological mechanisms and associated neuroimaging and clinical changes

This development represents an important step in addressing mental health and behavioral health challenges in the community. The initiative focuses on improving access to quality care and supporting those in need of mental health services.

[Psychedelic Therapy News]